IL1B and neoplasm: M2 macrophages promote tumor progression by enhancing angiogenesis and inhibiting an immune response against tumors, whereas M1 macrophages promote a proinflammatory microenvironment by releasing IL-1β, IL-6, IL-12, and tumor necrosis factor alpha (TNF-α).